Data:
{
"symbol": "BMRN",
"price": 54.375,
"marketCap": 10525573146,
"beta": 0.216,
"lastDividend": 0,
"range": "49.26-70.98",
"change": -0.305,
"changePercentage": -0.55779,
"volume": 664645,
"averageVolume": 2042131,
"companyName": "BioMarin Pharmaceutical Inc.",
"currency": "USD",
"cik": "0001048477",
"isin": "US09061G1013",
"cusip": "09061G101",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.biomarin.com",
"description": "BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutical products. Among these are Vimizim, an enzyme replacement therapy targeting mucopolysaccharidosis (MPS) IV type A, a specific lysosomal storage disorder, and Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for individuals with MPS VI. Another notable offering is Kuvan, a unique synthetic oral version of 6R-BH4, prescribed for phenylketonuria (PKU), an inherited metabolic condition. Further expanding its product portfolio, BioMarin provides Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme administered via subcutaneous injection to lower blood Phe levels. Also available are Brineura, a recombinant human tripeptidyl peptidase 1 used in treating ceroid lipofuscinosis type 2, a variant of Batten disease; Voxzogo, a daily injectable c-type natriuretic peptide analog for achondroplasia; and Aldurazyme, a refined protein mirroring the naturally occurring human enzyme alpha-L-iduronidase. Beyond its established products, BioMarin has a robust development pipeline. This includes valoctocogene roxaparvovec, an adeno-associated virus vector undergoing Phase III clinical trials for severe hemophilia A. Additionally, BMN 307, an AAV5-mediated gene therapy, is in Phase 1/2 trials, aiming to normalize blood phenylalanine levels in PKU patients, while BMN 255 is also in Phase 1/2 trials for primary hyperoxaluria. Its clientele spans specialty pharmacies, hospitals, international government health bodies, and a network of distributors and pharmaceutical wholesalers. These services reach patients and healthcare providers across the United States, Europe, Latin America, and other global markets. BioMarin maintains strategic licensing and collaborative alliances with partners such as Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc., and Asubio Pharma Co., Ltd. Established in 1996, the company's corporate headquarters are located in San Rafael, California.",
"ceo": "Alexander Hardy",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "3221",
"phone": "415 506 6700",
"address": "770 Lindaro Street",
"city": "San Rafael",
"state": "CA",
"zip": "94901",
"image": "https://images.financialmodelingprep.com/symbol/BMRN.png",
"ipoDate": "1999-07-26",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "BMRN",
"name": "BioMarin Pharmaceutical Inc.",
"price": 54.29,
"changePercentage": -0.71324,
"change": -0.39,
"volume": 818314.85227,
"dayLow": 54.075,
"dayHigh": 54.98,
"yearHigh": 70.98,
"yearLow": 49.26,
"marketCap": 10509119376,
"priceAvg50": 62.956,
"priceAvg200": 58.56285,
"exchange": "NASDAQ",
"open": 54.84,
"previousClose": 54.68,
"timestamp": 1792427134,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-09-08",
"v": 65.0051,
"c": 64.63
},
{
"t": "2026-09-09",
"v": 64.602,
"c": 64.41
},
{
"t": "2026-09-10",
"v": 65.2931,
"c": 65.51
},
{
"t": "2026-09-11",
"v": 65.5894,
"c": 65.68
},
{
"t": "2026-09-14",
"v": 66.3754,
"c": 66.41
},
{
"t": "2026-09-15",
"v": 64.5379,
"c": 64.45
},
{
"t": "2026-09-16",
"v": 64.8003,
"c": 64.73
},
{
"t": "2026-09-17",
"v": 65.3839,
"c": 65.08
},
{
"t": "2026-09-18",
"v": 64.1724,
"c": 63.94
},
{
"t": "2026-09-21",
"v": 64.1637,
"c": 64.06
},
{
"t": "2026-09-22",
"v": 63.8416,
"c": 63.37
},
{
"t": "2026-09-23",
"v": 62.2249,
"c": 62.21
},
{
"t": "2026-09-24",
"v": 61.4349,
"c": 61.35
},
{
"t": "2026-09-25",
"v": 60.5036,
"c": 60.26
},
{
"t": "2026-09-28",
"v": 59.3193,
"c": 59.46
},
{
"t": "2026-09-29",
"v": 59.6941,
"c": 59.87
},
{
"t": "2026-09-30",
"v": 60.1599,
"c": 60
},
{
"t": "2026-10-01",
"v": 58.8478,
"c": 58.44
},
{
"t": "2026-10-02",
"v": 57.5571,
"c": 57.18
},
{
"t": "2026-10-05",
"v": 57.6099,
"c": 57.54
},
{
"t": "2026-10-06",
"v": 56.3035,
"c": 56.22
},
{
"t": "2026-10-07",
"v": 55.254,
"c": 55.2
},
{
"t": "2026-10-08",
"v": 54.7134,
"c": 54.89
},
{
"t": "2026-10-09",
"v": 54.8634,
"c": 54.795
},
{
"t": "2026-10-12",
"v": 55.5271,
"c": 55.39
},
{
"t": "2026-10-13",
"v": 54.5371,
"c": 54.38
},
{
"t": "2026-10-14",
"v": 55.0846,
"c": 55.14
},
{
"t": "2026-10-15",
"v": 56.4219,
"c": 56.05
},
{
"t": "2026-10-16",
"v": 54.9171,
"c": 54.68
},
{
"t": "2026-10-19",
"v": 54.3813,
"c": 54.26
}
],
"vwap_summary": {
"days": 30,
"days_above": 7,
"days_below": 23,
"pct_days_above": 23,
"position": "below",
"gap_pct": -0.22,
"streak_days": 3
}
}
Data:
{
"volume": 818314.85227,
"avgVolume": 2042131,
"short_ratio": [
{
"symbol": "BMRN",
"file_date": "2026-10-16",
"date": "20261016",
"short_volume": 648911,
"short_exempt_volume": 62,
"total_volume": 1047299,
"short_volume_ratio": 0.6196,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 54.76,
"vah": 59.34,
"val": 53.95,
"profile": [
{
"price": 54.04,
"volume": 496871
},
{
"price": 54.22,
"volume": 922236
},
{
"price": 54.4,
"volume": 776451
},
{
"price": 54.58,
"volume": 1282209
},
{
"price": 54.76,
"volume": 2280399
},
{
"price": 54.94,
"volume": 1642812
},
{
"price": 55.12,
"volume": 1723940
},
{
"price": 55.3,
"volume": 908762
},
{
"price": 55.48,
"volume": 1101328
},
{
"price": 55.66,
"volume": 1097748
},
{
"price": 55.84,
"volume": 590104
},
{
"price": 56.02,
"volume": 1375750
},
{
"price": 56.2,
"volume": 884835
},
{
"price": 56.38,
"volume": 678572
},
{
"price": 56.56,
"volume": 613379
},
{
"price": 56.74,
"volume": 655819
},
{
"price": 56.92,
"volume": 377263
},
{
"price": 57.1,
"volume": 254271
},
{
"price": 57.28,
"volume": 614613
},
{
"price": 57.46,
"volume": 861881
},
{
"price": 57.64,
"volume": 1004454
},
{
"price": 57.81,
"volume": 689522
},
{
"price": 57.99,
"volume": 498074
},
{
"price": 58.17,
"volume": 41336
},
{
"price": 58.35,
"volume": 27672
},
{
"price": 58.53,
"volume": 384558
},
{
"price": 58.71,
"volume": 126911
},
{
"price": 58.89,
"volume": 670928
},
{
"price": 59.07,
"volume": 500354
},
{
"price": 59.25,
"volume": 743286
},
{
"price": 59.43,
"volume": 1090243
},
{
"price": 59.61,
"volume": 551237
},
{
"price": 59.79,
"volume": 731800
},
{
"price": 59.97,
"volume": 483250
},
{
"price": 60.15,
"volume": 103722
},
{
"price": 60.33,
"volume": 998456
},
{
"price": 60.51,
"volume": 523924
},
{
"price": 60.69,
"volume": 167872
},
{
"price": 60.87,
"volume": 301173
},
{
"price": 61.05,
"volume": 69410
},
{
"price": 61.23,
"volume": 481973
},
{
"price": 61.41,
"volume": 417605
},
{
"price": 61.59,
"volume": 80260
},
{
"price": 61.77,
"volume": 162542
},
{
"price": 61.95,
"volume": 240267
},
{
"price": 62.13,
"volume": 829463
},
{
"price": 62.31,
"volume": 464228
},
{
"price": 62.48,
"volume": 38359
},
{
"price": 62.66,
"volume": 88879
},
{
"price": 62.84,
"volume": 27351
},
{
"price": 63.02,
"volume": 0
},
{
"price": 63.2,
"volume": 15367
},
{
"price": 63.38,
"volume": 235813
},
{
"price": 63.56,
"volume": 84679
},
{
"price": 63.74,
"volume": 314203
},
{
"price": 63.92,
"volume": 355770
},
{
"price": 64.1,
"volume": 221959
},
{
"price": 64.28,
"volume": 57003
},
{
"price": 64.46,
"volume": 120664
},
{
"price": 64.64,
"volume": 202646
}
],
"sessions": 20
}
}
Data:
{
"symbol": "BMRN",
"marketCap": 10518798064,
"enterpriseValueTTM": 13846993064,
"evToSalesTTM": 4.064737908081162,
"evToOperatingCashFlowTTM": 16.15584036663637,
"evToFreeCashFlowTTM": 18.893994722177496,
"evToEBITDATTM": 35.90149980035987,
"netDebtToEBITDATTM": 8.62910753084051,
"currentRatioTTM": 2.3867984057653984,
"incomeQualityTTM": 3.313599424722993,
"grahamNumberTTM": 16.696329634110846,
"grahamNetNetTTM": -14.72176861405791,
"taxBurdenTTM": 0.48938367648045067,
"interestBurdenTTM": 0.6407270539704366,
"workingCapitalTTM": 2307627000,
"investedCapitalTTM": 8832733000,
"returnOnAssetsTTM": 0.006224451829078866,
"operatingReturnOnAssetsTTM": 0.026902809713160943,
"returnOnTangibleAssetsTTM": 0.01179187276696621,
"returnOnEquityTTM": 0.011828098208777879,
"returnOnInvestedCapitalTTM": 0.012458697091164433,
"returnOnCapitalEmployedTTM": 0.02716431888992694,
"earningsYieldTTM": 0.006959396423370362,
"freeCashFlowYieldTTM": 0.06967316945728183,
"capexToOperatingCashFlowTTM": 0.1449219392618503,
"capexToDepreciationTTM": 0.811974583916221,
"capexToRevenueTTM": 0.036461718292709416,
"salesGeneralAndAdministrativeToRevenueTTM": 0.5061832658469672,
"researchAndDevelopementToRevenueTTM": 0.289918082882299,
"stockBasedCompensationToRevenueTTM": 0.06320939208257818,
"intangiblesToTotalAssetsTTM": 0.47214051982344435,
"averageReceivablesTTM": 982480500,
"averagePayablesTTM": 401223000,
"averageInventoryTTM": 1527872500,
"daysOfSalesOutstandingTTM": 113.68536470524691,
"daysOfPayablesOutstandingTTM": 178.33282311332647,
"daysOfInventoryOutstandingTTM": 781.0823146940961,
"operatingCycleTTM": 894.767679399343,
"cashConversionCycleTTM": 716.4348562860166,
"freeCashFlowToEquityTTM": 4388181000,
"freeCashFlowToFirmTTM": 779098369.1905305,
"tangibleAssetValueTTM": 786580000,
"netCurrentAssetValueTTM": -1430127000,
"grossProfitMarginTTM": 0.7554833039493174,
"ebitMarginTTM": 0.06831416767499929,
"ebitdaMarginTTM": 0.11321916718477644,
"operatingProfitMarginTTM": 0.08021395996141624,
"pretaxProfitMarginTTM": 0.04377073539884472,
"continuousOperationsProfitMarginTTM": 0.021420683411739635,
"netProfitMarginTTM": 0.021420683411739635,
"bottomLineProfitMarginTTM": 0.020344541530094105,
"receivablesTurnoverTTM": 3.2106155523742115,
"payablesTurnoverTTM": 2.0467348277666795,
"inventoryTurnoverTTM": 0.4673003000240109,
"fixedAssetTurnoverTTM": 3.4410450972430136,
"assetTurnoverTTM": 0.2905813838632033,
"quickRatioTTM": 1.315567465306407,
"solvencyRatioTTM": 0.04182829638543065,
"cashRatioTTM": 0.5252446520304135,
"priceToEarningsRatioTTM": 143.00000000000003,
"priceToEarningsGrowthRatioTTM": -1.6070032573289905,
"forwardPriceToEarningsGrowthRatioTTM": 1.1244334380973062,
"priceToEarningsDilutedRatioTTM": 139.33333333333334,
"priceToEarningsDilutedGrowthRatioTTM": -1.575682326621924,
"priceToBookRatioTTM": 1.6586369693430179,
"priceToSalesRatioTTM": 3.087757539891517,
"priceToFreeCashFlowRatioTTM": 14.352727280666086,
"priceToOperatingCashFlowRatioTTM": 12.2337260891226,
"debtToAssetsRatioTTM": 0.3584442180035522,
"debtToEquityRatioTTM": 0.6647271015418024,
"debtToCapitalRatioTTM": 0.3993009430351433,
"longTermDebtToCapitalRatioTTM": 0.35817981404582566,
"financialLeverageRatioTTM": 1.854478516194715,
"workingCapitalTurnoverRatioTTM": 1.1133553229856141,
"operatingCashFlowRatioTTM": 0.515078762208563,
"operatingCashFlowSalesRatioTTM": 0.2515955726125707,
"freeCashFlowOperatingCashFlowRatioTTM": 0.8550780607381497,
"debtServiceCoverageRatioTTM": 0.41729654239006325,
"interestCoverageRatioTTM": 3.2682454132280827,
"shortTermOperatingCashFlowCoverageRatioTTM": 1.3021651375031715,
"operatingCashFlowCoverageRatioTTM": 0.2039619723002237,
"capitalExpenditureCoverageRatioTTM": 6.900266482034603,
"dividendPaidAndCapexCoverageRatioTTM": 6.900266482034603,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 17.654600200042495,
"netIncomePerShareTTM": 0.3781736016459455,
"interestDebtPerShareTTM": 22.21098782642945,
"cashPerShareTTM": 4.529485538378619,
"bookValuePerShareTTM": 32.761840598261806,
"tangibleBookValuePerShareTTM": 4.076410014562679,
"shareholdersEquityPerShareTTM": 32.761840598261806,
"operatingCashFlowPerShareTTM": 4.441819246575697,
"capexPerShareTTM": 0.6437170590643608,
"freeCashFlowPerShareTTM": 3.7981021875113368,
"netIncomePerEBTTTM": 0.48938367648045067,
"ebtPerEbitTTM": 0.5456747855348234,
"priceToFairValueTTM": 1.6586369693430179,
"debtToMarketCapTTM": 0.39796771214069004,
"effectiveTaxRateTTM": 0.5106163235195493,
"enterpriseValueMultipleTTM": 35.90149980035987,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 3221253000
}
],
"dcf": {
"symbol": "BMRN",
"date": "2026-10-19",
"dcf": 6.923855561563246,
"Stock Price": 54.68
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "BMRN",
"reportedCurrency": "USD",
"cik": "0001048477",
"filingDate": "2026-02-26",
"acceptedDate": "2026-02-26 12:30:49",
"fiscalYear": "2025",
"period": "FY",
"revenue": 3221253000,
"costOfRevenue": 736828000,
"grossProfit": 2484425000,
"researchAndDevelopmentExpenses": 921930000,
"generalAndAdministrativeExpenses": 1153017000,
"sellingAndMarketingExpenses": 124000000,
"sellingGeneralAndAdministrativeExpenses": 1277017000,
"otherExpenses": -248000000,
"operatingExpenses": 1950947000,
"costAndExpenses": 2687775000,
"netInterestIncome": 64005000,
"interestIncome": 74904000,
"interestExpense": 10899000,
"depreciationAndAmortization": 79557000,
"ebitda": 572936000,
"ebit": 493379000,
"nonOperatingIncomeExcludingInterest": 40098999,
"operatingIncome": 533477999,
"totalOtherIncomeExpensesNet": -50997999,
"incomeBeforeTax": 482480000,
"incomeTaxExpense": 133579000,
"netIncomeFromContinuingOperations": 348901000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 348901000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 348901000,
"eps": 1.82,
"epsDiluted": 1.8,
"weightedAverageShsOut": 191787000,
"weightedAverageShsOutDil": 197394000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "BMRN",
"reportedCurrency": "USD",
"cik": "0001048477",
"filingDate": "2026-02-26",
"acceptedDate": "2026-02-26 12:30:49",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 1311679000,
"shortTermInvestments": 248930000,
"cashAndShortTermInvestments": 1560609000,
"netReceivables": 908214000,
"accountsReceivables": 908214000,
"otherReceivables": 0,
"inventory": 1298883000,
"prepaids": 0,
"otherCurrentAssets": 185784000,
"totalCurrentAssets": 3953490000,
"propertyPlantEquipmentNet": 952508000,
"goodwill": 196199000,
"intangibleAssets": 213837000,
"goodwillAndIntangibleAssets": 410036000,
"longTermInvestments": 498208000,
"taxAssets": 1508697000,
"otherNonCurrentAssets": 277049000,
"totalNonCurrentAssets": 3640532000,
"otherAssets": 0,
"totalAssets": 7594022000,
"totalPayables": 316435000,
"accountPayables": 312768000,
"otherPayables": 3667000,
"accruedExpenses": 223187000,
"shortTermDebt": 8685000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 210724000,
"totalCurrentLiabilities": 759031000,
"longTermDebt": 597176000,
"capitalLeaseObligationsNonCurrent": 37012000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 0,
"otherNonCurrentLiabilities": 113804000,
"totalNonCurrentLiabilities": 747992000,
"otherLiabilities": 0,
"capitalLeaseObligations": 37012000,
"totalLiabilities": 1507023000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 192000,
"retainedEarnings": 154206000,
"additionalPaidInCapital": 5956582000,
"accumulatedOtherComprehensiveIncomeLoss": -13473000,
"otherTotalStockholdersEquity": -10508000,
"totalStockholdersEquity": 6086999000,
"totalEquity": 6086999000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 7594022000,
"totalInvestments": 747138000,
"totalDebt": 642873000,
"netDebt": -668806000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "BMRN",
"reportedCurrency": "USD",
"cik": "0001048477",
"filingDate": "2026-02-26",
"acceptedDate": "2026-02-26 12:30:49",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 348901000,
"depreciationAndAmortization": 79557000,
"deferredIncomeTax": 48738000,
"stockBasedCompensation": 181409000,
"changeInWorkingCapital": -108682000,
"accountsReceivables": -228054000,
"inventory": 119208000,
"accountsPayables": 66136000,
"otherWorkingCapital": -65972000,
"otherNonCashItems": 278071000,
"netCashProvidedByOperatingActivities": 827994000,
"investmentsInPropertyPlantAndEquipment": -103038000,
"acquisitionsNet": -285193000,
"purchasesOfInvestments": -355875000,
"salesMaturitiesOfInvestments": 337801000,
"otherInvestingActivities": -7937000,
"netCashProvidedByInvestingActivities": -414242000,
"netDebtIssuance": 0,
"longTermNetDebtIssuance": 0,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 14460000,
"netCommonStockIssuance": 14460000,
"commonStockIssuance": 14460000,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -56854000,
"netCashProvidedByFinancingActivities": -42394000,
"effectOfForexChangesOnCash": -2521000,
"netChangeInCash": 368837000,
"cashAtEndOfPeriod": 1311679000,
"cashAtBeginningOfPeriod": 942842000,
"operatingCashFlow": 827994000,
"capitalExpenditure": -103038000,
"freeCashFlow": 724956000,
"incomeTaxesPaid": 96205000,
"interestPaid": 7245000
}
]
}
}
Data:
{
"price": 54.2619,
"rsi": 30.213612244743842,
"sma20": 57.53459500000001,
"sma50": 62.765038000000004,
"sma200": 58.53700950000009,
"adx": 36.90612740803583,
"atr": 1.59,
"atr_pct": 2.93,
"atr_expansion_pct": 7.7,
"di_plus": 16.4,
"di_minus": 37.4,
"high_52w": 70.24,
"low_52w": 49.67,
"structure": {
"ema8": 55.27956997835271,
"ema21": 57.57815215286922,
"ema50": 59.95410940676067,
"ema200": 59.30680880751094,
"ema10": 55.609628850920565,
"ema20": 57.41701694876109,
"ema10_slope_pct": -2.28,
"ema20_slope_pct": -2.79,
"trend_dir": "down",
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": false,
"adx_over_30": true,
"higher_highs_lows": false,
"lower_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": -5.8,
"_no_bars": false,
"macd": {
"macd": -2.321,
"signal": -2.241,
"histogram": -0.08
},
"bollinger": {
"mid": 57.53,
"upper": 63.14,
"lower": 51.93,
"width_pct": 19.48
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": -5.7,
"ret_3d": -1.59,
"ret_5d": -2.04,
"roc10_accel": 1.15,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.37,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 6.34,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": false
},
"avg_dollar_vol": 111040873.125
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.4,
"iv_rank": 45.0
}
}
}
}
Data:
{
"prior_day": {
"high": 55.04,
"low": 54.08,
"close": 54.26,
"date": "2026-10-19"
},
"woodie_pivots": {
"PP": 54.41,
"R1": 54.74,
"S1": 53.78,
"R2": 55.37,
"S2": 53.44
},
"swing": {
"high_20d": 64.79,
"low_20d": 53.9,
"high_60d": 70.98,
"low_60d": 53.9
},
"orb": {
"high": 55.04,
"low": 54.36,
"date": "2026-10-19"
},
"vwap": 54.38,
"volume_profile": {
"poc": 54.76,
"vah": 59.34,
"val": 53.95,
"sessions": 20
},
"intraday": {
"h1_trend": "down",
"h1_last": 54.28,
"h1_ema9": 54.75,
"h1_ema21": 55.13,
"m15_trend": "down",
"m15_last": 54.25,
"m15_ema9": 54.34,
"m15_ema21": 54.52,
"rvol_intraday": 1.17,
"as_of_et": "2026-10-19 12:20"
},
"premarket": {
"date": "2026-10-19",
"high": 55.48,
"low": 54.52,
"last": 54.52,
"volume": 629,
"gap_pct": -0.29,
"path": "05:50 55.24 -> 08:55 54.52",
"bars": 2,
"last_bar_et": "08:55"
},
"recent_daily": [
{
"d": "2026-09-15",
"o": 65.78,
"h": 65.78,
"l": 63.85,
"c": 64.45,
"v": 1853761.25624
},
{
"d": "2026-09-16",
"o": 64.48,
"h": 65.67,
"l": 64.34,
"c": 64.73,
"v": 2252517.40285
},
{
"d": "2026-09-17",
"o": 65.34,
"h": 66.21,
"l": 64.97,
"c": 65.08,
"v": 1380832.088758
},
{
"d": "2026-09-18",
"o": 65.25,
"h": 65.29,
"l": 63.84,
"c": 63.94,
"v": 4455959.021552
},
{
"d": "2026-09-21",
"o": 64.35,
"h": 64.96,
"l": 63.58,
"c": 64.06,
"v": 1877054.848328
},
{
"d": "2026-09-22",
"o": 64.34,
"h": 64.79,
"l": 63.35,
"c": 63.37,
"v": 1962554.490173
},
{
"d": "2026-09-23",
"o": 63.68,
"h": 64,
"l": 61.58,
"c": 62.21,
"v": 2105164.849118
},
{
"d": "2026-09-24",
"o": 62.21,
"h": 62.33,
"l": 61.125,
"c": 61.35,
"v": 1659446.454985
},
{
"d": "2026-09-25",
"o": 61.5,
"h": 61.5,
"l": 60.17,
"c": 60.26,
"v": 1791426.350488
},
{
"d": "2026-09-28",
"o": 59.87,
"h": 60.07,
"l": 58.74,
"c": 59.46,
"v": 2357963.828626
},
{
"d": "2026-09-29",
"o": 59.235,
"h": 60.09,
"l": 58.96,
"c": 59.87,
"v": 1807502.046787
},
{
"d": "2026-09-30",
"o": 59.9,
"h": 60.705,
"l": 59.37,
"c": 60,
"v": 1797910.069233
},
{
"d": "2026-10-01",
"o": 59.81,
"h": 60.16,
"l": 58.39,
"c": 58.44,
"v": 2083189.97586
},
{
"d": "2026-10-02",
"o": 58.52,
"h": 58.73,
"l": 57.15,
"c": 57.18,
"v": 2192505.271678
},
{
"d": "2026-10-05",
"o": 57.11,
"h": 58.11,
"l": 56.82,
"c": 57.54,
"v": 2407511.463951
},
{
"d": "2026-10-06",
"o": 57.54,
"h": 57.875,
"l": 55.76,
"c": 56.22,
"v": 3718988.787369
},
{
"d": "2026-10-07",
"o": 56.05,
"h": 56.6,
"l": 54.76,
"c": 55.2,
"v": 2078982.808508
},
{
"d": "2026-10-08",
"o": 54.95,
"h": 54.97,
"l": 53.899,
"c": 54.89,
"v": 3098864.958409
},
{
"d": "2026-10-09",
"o": 54.8,
"h": 55.975,
"l": 54.48,
"c": 54.795,
"v": 2146377.627942
},
{
"d": "2026-10-12",
"o": 55.56,
"h": 55.96,
"l": 54.9,
"c": 55.39,
"v": 2365345.927476
},
{
"d": "2026-10-13",
"o": 55.3,
"h": 55.655,
"l": 53.93,
"c": 54.38,
"v": 2661697.073459
},
{
"d": "2026-10-14",
"o": 54.75,
"h": 55.56,
"l": 54.46,
"c": 55.14,
"v": 1845709.284769
},
{
"d": "2026-10-15",
"o": 56.45,
"h": 57.59,
"l": 55.955,
"c": 56.05,
"v": 2922503.28807
},
{
"d": "2026-10-16",
"o": 56.32,
"h": 56.53,
"l": 54.44,
"c": 54.68,
"v": 2627873.515388
},
{
"d": "2026-10-19",
"o": 54.78,
"h": 55.04,
"l": 54.075,
"c": 54.26,
"v": 814534.852273
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 3.45,
"etf_rvol": 0.99,
"rs_5d": -3.66,
"leading": false
}
Data:
{
"estimates": [
{
"symbol": "BMRN",
"date": "2030-12-31",
"revenueLow": 5312375882,
"revenueHigh": 5800910747,
"revenueAvg": 5546830300,
"ebitdaLow": 2321122543,
"ebitdaHigh": 2578588426,
"ebitdaAvg": 2444684249,
"ebitLow": 2138749825,
"ebitHigh": 2396215708,
"ebitAvg": 2262311531,
"netIncomeLow": 1783806160,
"netIncomeHigh": 1999921008,
"netIncomeAvg": 1887522890,
"sgaExpenseLow": 2043052701,
"sgaExpenseHigh": 2230935204,
"sgaExpenseAvg": 2133220028,
"epsAvg": 9.56221,
"epsHigh": 10.13162,
"epsLow": 9.03678,
"numAnalystsRevenue": 10,
"numAnalystsEps": 6
},
{
"symbol": "BMRN",
"date": "2029-12-31",
"revenueLow": 5040535157,
"revenueHigh": 5504071100,
"revenueAvg": 5262992258,
"ebitdaLow": 2160776852,
"ebitdaHigh": 2401118164,
"ebitdaAvg": 2276119611,
"ebitLow": 1997400387,
"ebitHigh": 2237741699,
"ebitAvg": 2112743146,
"netIncomeLow": 1665158548,
"netIncomeHigh": 1866899165,
"netIncomeAvg": 1761976357,
"sgaExpenseLow": 1938507213,
"sgaExpenseHigh": 2116775540,
"sgaExpenseAvg": 2024060569,
"epsAvg": 8.92619,
"epsHigh": 9.45773,
"epsLow": 8.43571,
"numAnalystsRevenue": 10,
"numAnalystsEps": 9
},
{
"symbol": "BMRN",
"date": "2028-12-31",
"revenueLow": 4452849731,
"revenueHigh": 5237088956,
"revenueAvg": 4879999198,
"ebitdaLow": 854215978,
"ebitdaHigh": 3026797775,
"ebitdaAvg": 1921077287,
"ebitLow": 711279711,
"ebitHigh": 2883861508,
"ebitAvg": 1778141020,
"netIncomeLow": 585598913,
"netIncomeHigh": 2409247078,
"netIncomeAvg": 1481113950,
"sgaExpenseLow": 1712493030,
"sgaExpenseHigh": 2014098583,
"sgaExpenseAvg": 1876767714,
"epsAvg": 7.83798,
"epsHigh": 12.20527,
"epsLow": 2.96665,
"numAnalystsRevenue": 20,
"numAnalystsEps": 15
},
{
"symbol": "BMRN",
"date": "2027-12-31",
"revenueLow": 4273026140,
"revenueHigh": 4769183204,
"revenueAvg": 4485664882,
"ebitdaLow": 1176498737,
"ebitdaHigh": 1973609668,
"ebitdaAvg": 1634247471,
"ebitLow": 1054652997,
"ebitHigh": 1851763928,
"ebitAvg": 1512401731,
"netIncomeLow": 873823763,
"netIncomeHigh": 1542912443,
"netIncomeAvg": 1258054470,
"sgaExpenseLow": 1643335824,
"sgaExpenseHigh": 1834149699,
"sgaExpenseAvg": 1725113199,
"epsAvg": 6.54397,
"epsHigh": 7.81641,
"epsLow": 4.4268,
"numAnalystsRevenue": 19,
"numAnalystsEps": 17
}
],
"price_target": {
"symbol": "BMRN",
"targetHigh": 124,
"targetLow": 59,
"targetConsensus": 91.06,
"targetMedian": 90
},
"ratings": {
"symbol": "BMRN",
"rating": "B",
"overallScore": 3,
"discountedCashFlowScore": 5,
"returnOnEquityScore": 2,
"returnOnAssetsScore": 4,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 3
},
"grades": [
{
"symbol": "BMRN",
"date": "2026-10-14",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-09-10",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-09-01",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-08-31",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-08-31",
"gradingCompany": "Jefferies",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-08-19",
"gradingCompany": "BMO Capital",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-08-18",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-08-17",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-08-17",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-08-10",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-08-07",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-08-07",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-08-07",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-07-16",
"gradingCompany": "Citigroup",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-07-07",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-05-22",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-05-19",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-05-18",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-05-07",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-05-05",
"gradingCompany": "Bernstein",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-05-05",
"gradingCompany": "RBC Capital",
"previousGrade": "Sector Perform",
"newGrade": "Sector Perform",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-05-05",
"gradingCompany": "Evercore ISI Group",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-05-05",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-05-05",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-03-11",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-03-04",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-03-02",
"gradingCompany": "Freedom Broker",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-03-02",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-02-26",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-02-25",
"gradingCompany": "Guggenheim",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-02-25",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-02-25",
"gradingCompany": "Bernstein",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-02-24",
"gradingCompany": "Oppenheimer",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-02-18",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-02-06",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2026-01-20",
"gradingCompany": "Canaccord Genuity",
"previousGrade": "Hold",
"newGrade": "Buy",
"action": "upgrade"
},
{
"symbol": "BMRN",
"date": "2025-12-23",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2025-12-22",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2025-12-03",
"gradingCompany": "Leerink Partners",
"previousGrade": "Outperform",
"newGrade": "Market Perform",
"action": "downgrade"
},
{
"symbol": "BMRN",
"date": "2025-11-06",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Hold",
"action": "downgrade"
},
{
"symbol": "BMRN",
"date": "2025-11-03",
"gradingCompany": "Freedom Broker",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2025-11-03",
"gradingCompany": "Bernstein",
"previousGrade": "Outperform",
"newGrade": "Outperform",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2025-10-28",
"gradingCompany": "Stifel",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2025-10-28",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2025-10-28",
"gradingCompany": "Wells Fargo",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2025-10-28",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2025-10-28",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "BMRN",
"date": "2025-10-27",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
}
]
}
Data:
[
{
"title": "BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: Should You Buy?",
"url": "https://www.zacks.com/stock/news/3010591/biomarin-pharmaceutical-bmrn-earnings-expected-to-grow-should-you-buy?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_9-3010591",
"source": "Zacks Investment Research",
"date": "2026-10-19 11:01:09",
"summary": "BioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
"image": "https://images.financialmodelingprep.com/news/biomarin-pharmaceutical-bmrn-earnings-expected-to-grow-should-you-20261019.jpg"
},
{
"title": "BioMarin Pharmaceutical Inc. $BMRN Stock: Assenagon Asset Management S.A. Lowers Position",
"url": "https://www.defenseworld.net/2026/10/17/biomarin-pharmaceutical-inc-bmrn-stock-assenagon-asset-management-s-a-lowers-position.html",
"source": "Defense World",
"date": "2026-10-17 03:49:00",
"summary": "Assenagon Asset Management S.A. trimmed its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) by 24.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,339,560 share",
"image": "https://images.financialmodelingprep.com/news/biomarin-pharmaceutical-inc-bmrn-stock-assenagon-asset-management-sa-20261017.png"
},
{
"title": "Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock",
"url": "https://www.zacks.com/stock/news/3005948/here-s-why-biomarin-pharmaceutical-bmrn-is-a-strong-value-stock?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|zacks_education_value_score-3005948",
"source": "Zacks Investment Research",
"date": "2026-10-13 10:41:16",
"summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
"image": "https://images.financialmodelingprep.com/news/heres-why-biomarin-pharmaceutical-bmrn-is-a-strong-value-20261013.jpg"
},
{
"title": "Raymond James upgrades BioMarin stock to strong buy on valuation By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/raymond-james-upgrades-biomarin-stock-to-strong-buy-on-valuation-93CH-4943690",
"source": "Investing.com",
"date": "2026-10-12T09:56:45Z",
"summary": "Investing.com - Raymond James upgraded BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to Strong Buy from Outperform on Monday with a price target of $109.00.\n\nThe upgrade follows investor meetings with management held over two days last week in Boston and New York. The analyst noted ",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM450ND_1200_L.jpg"
},
{
"title": "Financial Review: Relay Therapeutics (NASDAQ:RLAY) & BioMarin Pharmaceutical (NASDAQ:BMRN)",
"url": "https://www.defenseworld.net/2026/10/12/financial-review-relay-therapeutics-nasdaqrlay-biomarin-pharmaceutical-nasdaqbmrn.html",
"source": "Defense World",
"date": "2026-10-12 01:59:01",
"summary": "Relay Therapeutics (NASDAQ: RLAY - Get Free Report) and BioMarin Pharmaceutical (NASDAQ: BMRN - Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, va",
"image": "https://images.financialmodelingprep.com/news/financial-review-relay-therapeutics-nasdaqrlay-biomarin-pharmaceutical-nasdaqbmrn-20261012.png"
},
{
"title": "BioMarin Presents New Data Advancing Understanding of Achondroplasia and Hypochondroplasia Treatment at the American Society for Bone and Mineral Research Annual Meeting",
"url": "https://www.prnewswire.com/news-releases/biomarin-presents-new-data-advancing-understanding-of-achondroplasia-and-hypochondroplasia-treatment-at-the-american-society-for-bone-and-mineral-research-annual-meeting-302903104.html",
"source": "PRNewsWire",
"date": "2026-10-09 09:05:00",
"summary": "New analysis showcases impact of VOXZOGO\u00ae\u00a0(vosoritide) in foramen magnum and craniocervical junction growth in children with achondroplasia, including infants SAN RAFAEL, Calif., Oct. 9, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced it will pres",
"image": "https://images.financialmodelingprep.com/news/biomarin-presents-new-data-advancing-understanding-of-achondroplasia-and-20261009.jpg"
},
{
"title": "FDA Grants Priority Review to BridgeBio's Dwarfism Drug Filing",
"url": "https://www.zacks.com/stock/news/3002048/fda-grants-priority-review-to-bridgebio-s-dwarfism-drug-filing?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-3002048",
"source": "Zacks Investment Research",
"date": "2026-10-07T14:37:00Z",
"summary": "BridgeBio Pharma announced FDA acceptance of its regulatory filing for infigratinib, an oral drug to treat achondroplasia in children, with priority review and a decision expected by February 4, 2027. The drug demonstrated 2.1 cm/year greater height growth than placebo in Phase I",
"image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg"
},
{
"title": "BioMarin Appoints Cara Bauer as Chief People Officer",
"url": "https://www.prnewswire.com/news-releases/biomarin-appoints-cara-bauer-as-chief-people-officer-302898849.html",
"source": "PRNewsWire",
"date": "2026-10-05 16:05:00",
"summary": "Ms. Bauer Brings More Than 25 Years of Experience in Human Resources, Across Biotechnology and Technology Industries Appointment Effective Oct. 5, 2026 SAN RAFAEL, Calif., Oct. 5, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that\u00a0Cara Bauer, Ph",
"image": "https://images.financialmodelingprep.com/news/biomarin-appoints-cara-bauer-as-chief-people-officer-20261005.jpg"
},
{
"title": "BioMarin reports five-year Pompe disease data showing durable motor function",
"url": "https://www.cnbc.com/2026/10/02/biomarin-reports-five-year-pompe-disease-data-.html",
"source": "CNBC",
"date": "2026-10-02T16:18:35Z",
"summary": "* A BioMarin combination therapy helped adults with late-onset Pompe disease maintain walking distance over five years of continuous therapy.\n\n* Respiratory function remained relatively stable, with no new safety signals identified.\n\n* Late-onset Pompe disease is a rare disease t",
"image": "https://image.cnbcfm.com/api/v1/image/108244124-1766150506856-gettyimages-2194937313-PSWAT_DSC04764.jpeg?v=1766150530&w=1920&h=1080"
},
{
"title": "BioMarin presents five-year data on Pompe disease treatment By Investing.com",
"url": "https://www.investing.com/news/company-news/biomarin-presents-fiveyear-data-on-pompe-disease-treatment-93CH-4930112",
"source": "Investing.com",
"date": "2026-10-02T15:04:33Z",
"summary": "SAN RAFAEL, Calif. - BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) presented data from a five-year study of POMBILITI and OPFOLDA for late-onset Pompe disease at the World Muscle Society Congress in Hiroshima, Japan, according to a press release statement issued today.\n\nThe PROPEL o",
"image": "https://content-media.investing.com/news/LYNXMPEM0J0ZC_1200_L.jpg"
},
{
"title": "BioMarin Announces Five-Year Phase 3 Data for POMBILITI\u00ae (cipaglucosidase alfa-atga) + OPFOLDA\u00ae (miglustat) at World Muscle Society Annual Congress",
"url": "https://www.prnewswire.com/news-releases/biomarin-announces-five-year-phase-3-data-for-pombiliti-cipaglucosidase-alfa-atga--opfolda-miglustat-at-world-muscle-society-annual-congress-302896737.html",
"source": "PRNewsWire",
"date": "2026-10-02 11:00:00",
"summary": "Long-term data reinforce durable efficacy and safety of POMBILITI + OPFOLDA in late-onset Pompe disease SAN RAFAEL, Calif., Oct. 2, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced new data evaluating the efficacy and safety of POMBILITI\u00ae\u00a0(cipagluc",
"image": "https://images.financialmodelingprep.com/news/biomarin-announces-fiveyear-phase-3-data-for-pombiliti-cipaglucosidase-20261002.jpg"
},
{
"title": "Profluent Partners With BioMarin to Design Novel Medicines Using AI",
"url": "https://www.businesswire.com/news/home/20260930437951/en/Profluent-Partners-With-BioMarin-to-Design-Novel-Medicines-Using-AI/",
"source": "Business Wire",
"date": "2026-09-30 07:00:00",
"summary": "EMERYVILLE, Calif.--(BUSINESS WIRE)---- $BMRN--Profluent, the frontier AI lab for biology, today announced a collaboration with BioMarin Pharmaceutical Inc. to design and optimize novel enzyme therapies for BioMarin's pipeline. Under the agreement, Profluent will apply its founda",
"image": "https://images.financialmodelingprep.com/news/profluent-partners-with-biomarin-to-design-novel-medicines-using-20260930.jpg"
},
{
"title": "Reviewing Metagenomi (NASDAQ:MGX) and BioMarin Pharmaceutical (NASDAQ:BMRN)",
"url": "https://www.defenseworld.net/2026/09/30/reviewing-metagenomi-nasdaqmgx-and-biomarin-pharmaceutical-nasdaqbmrn.html",
"source": "Defense World",
"date": "2026-09-30 02:29:01",
"summary": "BioMarin Pharmaceutical (NASDAQ: BMRN - Get Free Report) and Metagenomi (NASDAQ: MGX - Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, institutional ownership, di",
"image": "https://images.financialmodelingprep.com/news/reviewing-metagenomi-nasdaqmgx-and-biomarin-pharmaceutical-nasdaqbmrn-20260930.png"
},
{
"title": "Enzyme Replacement Therapy Market to Grow to USD 27.90 Billion by 2035 at a CAGR of 8.59% - SNS Insider",
"url": "https://www.globenewswire.com/news-release/2026/09/25/3369104/0/en/enzyme-replacement-therapy-market-to-grow-to-usd-27-90-billion-by-2035-at-a-cagr-of-8-59-sns-insider.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-25T12:30:00Z",
"summary": "The global Enzyme Replacement Therapy (ERT) market is projected to grow from USD 12.24 billion in 2025 to USD 27.90 billion by 2035, with a CAGR of 8.59%. Growth is driven by early identification of rare lysosomal storage disorders, increased newborn screening, orphan drug incent",
"image": "https://ml.globenewswire.com/Resource/Download/d6272c2e-d204-41b8-b545-a6e2e24f85c2"
},
{
"title": "BioMarin: Why I See Significant Upside Into 2027",
"url": "https://seekingalpha.com/article/4948323-biomarin-why-i-see-significant-upside-into-2027",
"source": "Seeking Alpha",
"date": "2026-09-21 10:05:29",
"summary": "Q4 2026/ 2027 will be rich in catalysts for BioMarin Pharmaceutical Inc. From the presentation of 12 mg/kg BMN 351 Phase 1/2 data in Duchenne muscular dystrophy by year-end 2026 to a potential H1 2027 approval of Voxzogo for hypochondroplasia. BioMarin raised its full-year 2026 r",
"image": "https://images.financialmodelingprep.com/news/biomarin-why-i-see-significant-upside-into-2027-20260921.jpg"
},
{
"title": "BioMarin Targets Amicus Synergies as VOXZOGO Nears $1B Milestone",
"url": "https://finance.yahoo.com/healthcare/articles/biomarin-targets-amicus-synergies-voxzogo-170213209.html",
"source": "Yahoo! Finance",
"date": "2026-09-18T17:02:13Z",
"summary": "* Can BioMarin Stock Live Up to Wall Street's High Expectations?\n\nBioMarin Pharmaceutical (NASDAQ:BMRN) said it is progressing with the integration of Amicus Therapeutics while pursuing additional business-development opportunities, as executives outlined growth plans for newly a",
"image": "https://s.yimg.com/lo/mysterio/api/8bb6818253a3f96db6d0e13388d25e8180fb53d90119f6b04ebf88338e4c437c/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fmarketbeat_955%2Fde1d1e96eec97ca453a0a9a0e0e4a934.png"
},
{
"title": "BioMarin options flow shows large bullish call spread targeting $100 by April 2027 By Investing.com",
"url": "https://www.investing.com/news/stock-market-news/biomarin-options-flow-shows-large-bullish-call-spread-targeting-100-by-april-2027-93CH-4906083",
"source": "Investing.com",
"date": "2026-09-17T15:42:43Z",
"summary": "Investing.com -- The options flow on BioMarin Pharmaceutical Inc. (BMRN) is notable -- a call-to-put ratio of 182:1 (2,183 calls vs. 12 puts) is not hedging activity. Someone is making a directional bet, and a sizeable one.\n\nThe Trade Decoded\n\nThe dominant position is a $90/$100 ",
"image": "https://content-media.investing.com/news/LYNXNPEBAG0BO_L.jpg"
},
{
"title": "BioMarin Stops Voxzogo Development for Noonan Syndrome",
"url": "https://www.zacks.com/stock/news/2990871/biomarin-stops-voxzogo-development-for-noonan-syndrome?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2990871",
"source": "Zacks Investment Research",
"date": "2026-09-16T16:01:00Z",
"summary": "BioMarin Pharmaceutical announced it is discontinuing development of Voxzogo for Noonan syndrome due to study feasibility and treatment landscape concerns, though not due to safety or efficacy issues. Despite this setback, Voxzogo generated $472 million in first-half 2026 sales (",
"image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg"
},
{
"title": "BMO cuts BioMarin stock price target to $97 on Voxzogo focus shift By Investing.com",
"url": "https://www.investing.com/news/analyst-ratings/bmo-cuts-biomarin-stock-price-target-to-97-on-voxzogo-focus-shift-93CH-4903878",
"source": "Investing.com",
"date": "2026-09-16T13:28:51Z",
"summary": "Investing.com - BMO Capital lowered its price target on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to $97 from $98 while maintaining an Outperform rating on the stock. With shares currently trading at $64.45, the target suggests significant upside potential. According to Investin",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM4510G_1200_L.jpg"
},
{
"title": "BioMarin to discontinue development of Voxzogo for Noonan syndrome in children By Investing.com",
"url": "https://www.investing.com/news/sec-filings/biomarin-to-discontinue-development-of-voxzogo-for-noonan-syndrome-in-children-93CH-4901747",
"source": "Investing.com",
"date": "2026-09-15T12:52:38Z",
"summary": "BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced Tuesday it will discontinue development of Voxzogo for children with Noonan syndrome. The decision follows an assessment of several factors, including the feasibility of the study and the current treatment landscape for childre",
"image": "https://content-media.investing.com/news/moved_LYNXMPEM3Q0V4_1200_L.jpg"
},
{
"title": "BioMarin at Morgan Stanley conference: growth, deals and pipeline bets By Investing.com",
"url": "https://www.investing.com/news/transcripts/biomarin-at-morgan-stanley-conference-growth-deals-and-pipeline-bets-93CH-4899954",
"source": "Investing.com",
"date": "2026-09-14T14:47:48Z",
"summary": "BioMarin Pharmaceutical (BMRN) used Monday, 14 September 2026, at the Morgan Stanley 24th Annual Global Healthcare Conference to outline a business that is growing steadily even as it absorbs a large acquisition and prepares for more deal-making. Management pointed to strong sale",
"image": "https://content-media.investing.com/news/LYNXNPEC0E0NI_L.jpg"
},
{
"title": "BioMarin Pharmaceutical Inc. (BMRN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4946075-biomarin-pharmaceutical-inc-bmrn-presents-at-morgan-stanley-24th-annual-global-healthcare",
"source": "Seeking Alpha",
"date": "2026-09-14 12:11:37",
"summary": "BioMarin Pharmaceutical Inc. (BMRN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/biomarin-pharmaceutical-inc-bmrn-presents-at-morgan-stanley-24th-20260914.jpg"
},
{
"title": "BioMarin Shares Jump 5% After Global Patent Settlement With Ascendis",
"url": "https://finance.yahoo.com/healthcare/articles/biomarin-shares-jump-5-global-170253036.html",
"source": "Yahoo! Finance",
"date": "2026-09-12T17:02:53Z",
"summary": "BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)'s stock rose 5% on August 31 after the company announced that it has entered into binding agreements with Ascendis Pharma A/S (NASDAQ:ASND) to resolve a global patent dispute over Ascendis's achondroplasia drug Yuviwel. The settlement re",
"image": "https://s.yimg.com/lo/mysterio/api/3b665dc25564ee6cda90eb8cf0e0d55896557f9a3b6b2b4d375ad8d81455d70a/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2Fae3aff8170c32ab72e21b7d307dd751f.jpg"
},
{
"title": "BioMarin at Citi summit: voxzogo drives growth as pipeline widens By Investing.com",
"url": "https://www.investing.com/news/transcripts/biomarin-at-citi-summit-voxzogo-drives-growth-as-pipeline-widens-93CH-4896671",
"source": "Investing.com",
"date": "2026-09-10T18:02:58Z",
"summary": "BioMarin Pharmaceutical Inc. (BMRN) used Citi's Biopharma Back to School Summit 2026 on Thursday, 10 September 2026, to outline a business that is growing quickly but still faces competitive and regulatory tests. Management said the rare-disease company is benefiting from strong ",
"image": "https://content-media.investing.com/news/LYNXNPEC0D0AP_L.jpg"
},
{
"title": "BioMarin at Wells Fargo conference: growth, pipeline and integration By Investing.com",
"url": "https://www.investing.com/news/transcripts/biomarin-at-wells-fargo-conference-growth-pipeline-and-integration-93CH-4894751",
"source": "Investing.com",
"date": "2026-09-09T23:32:03Z",
"summary": "On Wednesday, 09 September 2026, BioMarin Pharmaceutical Inc. (BMRN) used the Wells Fargo 21st Annual Healthcare Conference to outline a business that is growing, changing and still facing competitive pressure. Management said the company's rare-disease portfolio has expanded thr",
"image": "https://content-media.investing.com/news/LYNXNPEB8506G_L.jpg"
}
]
Data:
[
{
"symbol": "BMRN",
"date": "2026-10-26",
"epsActual": null,
"epsEstimated": 1.33,
"revenueActual": null,
"revenueEstimated": 1022214000,
"lastUpdated": "2026-10-19"
},
{
"symbol": "BMRN",
"date": "2026-08-06",
"epsActual": 1.2,
"epsEstimated": 0.947,
"revenueActual": 989708000,
"revenueEstimated": 932031800,
"lastUpdated": "2026-10-19"
},
{
"symbol": "BMRN",
"date": "2026-05-04",
"epsActual": 0.76,
"epsEstimated": 0.78,
"revenueActual": 766000000,
"revenueEstimated": 752533000,
"lastUpdated": "2026-08-17"
},
{
"symbol": "BMRN",
"date": "2026-02-23",
"epsActual": -0.24,
"epsEstimated": 0.1694,
"revenueActual": 874565000,
"revenueEstimated": 833732100,
"lastUpdated": "2026-08-17"
},
{
"symbol": "BMRN",
"date": "2025-10-27",
"epsActual": -0.16,
"epsEstimated": -0.15,
"revenueActual": 776133000,
"revenueEstimated": 777477900,
"lastUpdated": "2026-08-17"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "BMRN",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "BMRN",
"periods": [
{
"file_period": "202607a",
"settlement_date": "20260710",
"quantity_fails": 114,
"price": 59.97
},
{
"file_period": "202607b",
"settlement_date": "20260730",
"quantity_fails": 74,
"price": 61.37
},
{
"file_period": "202608a",
"settlement_date": "20260811",
"quantity_fails": 5650,
"price": 68.88
},
{
"file_period": "202608b",
"settlement_date": "20260824",
"quantity_fails": 260,
"price": 66.7
},
{
"file_period": "202609a",
"settlement_date": "20260902",
"quantity_fails": 47834,
"price": 64.84
},
{
"file_period": "202609b",
"settlement_date": "20260930",
"quantity_fails": 260,
"price": 59.87
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "BMRN",
"filingDate": "2026-10-01",
"transactionDate": "2026-09-30",
"reportingCik": "0002038768",
"companyCik": "0001048477",
"transactionType": "F-InKind",
"securitiesOwned": 47732,
"reportingName": "Friberg Gregory R",
"typeOfOwner": "officer: EVP, Chief R&D Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 4086,
"price": 60,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1048477/000162828026064272/0001628280-26-064272-index.htm"
},
{
"symbol": "BMRN",
"filingDate": "2026-09-14",
"transactionDate": "2026-09-10",
"reportingCik": "0001773367",
"companyCik": "0001048477",
"transactionType": "A-Award",
"securitiesOwned": 6140,
"reportingName": "Plenge Robert M",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 6140,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1048477/000162828026061940/0001628280-26-061940-index.htm"
},
{
"symbol": "BMRN",
"filingDate": "2026-09-14",
"transactionDate": "2026-09-10",
"reportingCik": "0001773367",
"companyCik": "0001048477",
"transactionType": "",
"securitiesOwned": 0,
"reportingName": "Plenge Robert M",
"typeOfOwner": "director: ",
"acquisitionOrDisposition": "",
"directOrIndirect": null,
"formType": "3",
"securitiesTransacted": 0,
"price": 0,
"securityName": "",
"url": "https://www.sec.gov/Archives/edgar/data/1048477/000162828026061934/0001628280-26-061934-index.htm"
},
{
"symbol": "BMRN",
"filingDate": "2026-09-03",
"transactionDate": "2026-09-02",
"reportingCik": "0001380710",
"companyCik": "0001048477",
"transactionType": "S-Sale",
"securitiesOwned": 61003,
"reportingName": "Davis George Eric",
"typeOfOwner": "officer: EVP, Chief Legal Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 17557,
"price": 66.284,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1048477/000162828026060572/0001628280-26-060572-index.htm"
},
{
"symbol": "BMRN",
"filingDate": "2026-06-04",
"transactionDate": "2026-06-02",
"reportingCik": "0001571469",
"companyCik": "0001048477",
"transactionType": "A-Award",
"securitiesOwned": 21040,
"reportingName": "Countouriotis Athena",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7490,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1048477/000162828026040922/0001628280-26-040922-index.htm"
},
{
"symbol": "BMRN",
"filingDate": "2026-06-04",
"transactionDate": "2026-06-02",
"reportingCik": "0001349376",
"companyCik": "0001048477",
"transactionType": "A-Award",
"securitiesOwned": 17270,
"reportingName": "Walbert Timothy P",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7490,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1048477/000162828026040920/0001628280-26-040920-index.htm"
},
{
"symbol": "BMRN",
"filingDate": "2026-06-04",
"transactionDate": "2026-06-02",
"reportingCik": "0001646395",
"companyCik": "0001048477",
"transactionType": "A-Award",
"securitiesOwned": 35500,
"reportingName": "Ho Maykin",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7490,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1048477/000162828026040918/0001628280-26-040918-index.htm"
},
{
"symbol": "BMRN",
"filingDate": "2026-06-04",
"transactionDate": "2026-06-02",
"reportingCik": "0001496182",
"companyCik": "0001048477",
"transactionType": "A-Award",
"securitiesOwned": 49360,
"reportingName": "HOMBACH ROBERT J.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7490,
"price": 0,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1048477/000162828026040916/0001628280-26-040916-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "BMRN",
"senateID": "G000599",
"disclosureDate": "2023-04-17",
"transactionDate": "2023-03-06",
"firstName": "Daniel",
"lastName": "Goldman",
"office": "Daniel Goldman",
"district": "NY10",
"owner": "",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022653.pdf"
},
{
"symbol": "BMRN",
"senateID": "K000389",
"disclosureDate": "2023-04-07",
"transactionDate": "2023-03-14",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Biomarin Pharmaceutical Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219444.pdf"
},
{
"symbol": "BMRN",
"senateID": "K000389",
"disclosureDate": "2023-01-03",
"transactionDate": "2022-12-06",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Biomarin Pharmaceutical Inc",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8219318.pdf"
},
{
"symbol": "BMRN",
"senateID": "K000389",
"disclosureDate": "2022-06-10",
"transactionDate": "2022-05-10",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "",
"assetDescription": "Biomarin Pharmaceutical Inc",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/8218940.pdf"
},
{
"symbol": "BMRN",
"senateID": "G000583",
"disclosureDate": "2021-11-15",
"transactionDate": "2021-10-18",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "BioMarin Pharmaceutical Inc",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2021/20019761.pdf"
},
{
"symbol": "BMRN",
"senateID": "C001123",
"disclosureDate": "2021-01-11",
"transactionDate": "2020-12-30",
"firstName": "Gilbert",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2021/20017992.pdf"
},
{
"symbol": "BMRN",
"senateID": "G000583",
"disclosureDate": "2020-11-05",
"transactionDate": "2020-10-16",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20017634.pdf"
},
{
"symbol": "BMRN",
"senateID": "G000583",
"disclosureDate": "2020-10-13",
"transactionDate": "2020-09-15",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20017476.pdf"
},
{
"symbol": "BMRN",
"senateID": "G000583",
"disclosureDate": "2020-01-06",
"transactionDate": "2019-12-11",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20013859.pdf"
},
{
"symbol": "BMRN",
"senateID": "G000583",
"disclosureDate": "2020-01-06",
"transactionDate": "2019-12-16",
"firstName": "Josh",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20013859.pdf"
},
{
"symbol": "BMRN",
"senateID": "L000579",
"disclosureDate": "2019-09-01",
"transactionDate": "2019-08-15",
"firstName": "Alan",
"lastName": "Lowenthal",
"office": "Alan S. Lowenthal",
"district": "CA47",
"owner": "Spouse",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2019/20012239.pdf"
},
{
"symbol": "BMRN",
"senateID": "L000579",
"disclosureDate": "2019-09-01",
"transactionDate": "2019-08-14",
"firstName": "Alan",
"lastName": "Lowenthal",
"office": "Alan S. Lowenthal",
"district": "CA47",
"owner": "Spouse",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2019/20012239.pdf"
},
{
"symbol": "BMRN",
"senateID": "L000579",
"disclosureDate": "2019-09-01",
"transactionDate": "2019-08-14",
"firstName": "Alan",
"lastName": "Lowenthal",
"office": "Alan S. Lowenthal",
"district": "CA47",
"owner": "Spouse",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2019/20012240.pdf"
},
{
"symbol": "BMRN",
"senateID": "L000579",
"disclosureDate": "2019-09-01",
"transactionDate": "2019-08-15",
"firstName": "Alan",
"lastName": "Lowenthal",
"office": "Alan S. Lowenthal",
"district": "CA47",
"owner": "Spouse",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$50,001 - $100,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2019/20012240.pdf"
},
{
"symbol": "BMRN",
"senateID": "T000479",
"disclosureDate": "2019-04-15",
"transactionDate": "2019-03-25",
"firstName": "Van",
"lastName": "Taylor",
"office": "Van Taylor",
"district": "TX03",
"owner": "Spouse",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2019/20011315.pdf"
},
{
"symbol": "BMRN",
"senateID": "L000579",
"disclosureDate": "2018-06-10",
"transactionDate": "2018-05-29",
"firstName": "Alan",
"lastName": "Lowenthal",
"office": "Alan S. Lowenthal",
"district": "CA47",
"owner": "Spouse",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$50,001 - $100,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2018/20009712.pdf"
},
{
"symbol": "BMRN",
"senateID": "L000579",
"disclosureDate": "2018-05-03",
"transactionDate": "2018-04-27",
"firstName": "Alan",
"lastName": "Lowenthal",
"office": "Alan S. Lowenthal",
"district": "CA47",
"owner": "Spouse",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2018/20009438.pdf"
},
{
"symbol": "BMRN",
"senateID": "L000579",
"disclosureDate": "2018-05-03",
"transactionDate": "2018-04-26",
"firstName": "Alan",
"lastName": "Lowenthal",
"office": "Alan S. Lowenthal",
"district": "CA47",
"owner": "Spouse",
"assetDescription": "BioMarin Pharmaceutical Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2018/20009438.pdf"
}
],
"dark_pool": [
{
"ticker": "BMRN",
"executed_at": "2026-10-19T15:46:37.720000Z",
"size": 200.0,
"price": 54.39,
"premium": 10878.0,
"volume": 200.0,
"trade_code": "F"
},
{
"ticker": "BMRN",
"executed_at": "2026-10-19T15:44:53.648000Z",
"size": 200.0,
"price": 54.345,
"premium": 10869.0,
"volume": 200.0,
"trade_code": " "
},
{
"ticker": "BMRN",
"executed_at": "2026-10-19T15:46:37.721000Z",
"size": 156.0,
"price": 54.4,
"premium": 8486.4,
"volume": 156.0,
"trade_code": " "
},
{
"ticker": "BMRN",
"executed_at": "2026-10-19T15:48:40.203000Z",
"size": 148.0,
"price": 54.4,
"premium": 8051.2,
"volume": 148.0,
"trade_code": "F"
},
{
"ticker": "BMRN",
"executed_at": "2026-10-19T15:42:45.050000Z",
"size": 110.0,
"price": 54.35,
"premium": 5978.5,
"volume": 110.0,
"trade_code": " "
},
{
"ticker": "BMRN",
"executed_at": "2026-10-19T15:42:12.765000Z",
"size": 108.0,
"price": 54.23,
"premium": 5856.839999999999,
"volume": 108.0,
"trade_code": " "
},
{
"ticker": "BMRN",
"executed_at": "2026-10-19T15:46:26.727000Z",
"size": 105.0,
"price": 54.35,
"premium": 5706.75,
"volume": 105.0,
"trade_code": " "
},
{
"ticker": "BMRN",
"executed_at": "2026-10-19T15:49:00.186000Z",
"size": 100.0,
"price": 54.375,
"premium": 5437.5,
"volume": 100.0,
"trade_code": " "
}
],
"ats": {
"symbol": "BMRN",
"date": "20261016",
"ats_volume": 0,
"total_volume": 1047299,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20261016",
"ats_ratio": 0.0
},
{
"date": "20261015",
"ats_ratio": 0.0
},
{
"date": "20261014",
"ats_ratio": 0.0
},
{
"date": "20261013",
"ats_ratio": 0.0
},
{
"date": "20261012",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "BMRN",
"days": [
{
"date": "2026-10-19",
"close": 54.26,
"vwap": 54.38,
"volume": 814534,
"vwap_discount_pct": 0.22
},
{
"date": "2026-10-16",
"close": 54.68,
"vwap": 54.92,
"volume": 2627873,
"vwap_discount_pct": 0.43
},
{
"date": "2026-10-15",
"close": 56.05,
"vwap": 56.42,
"volume": 2922503,
"vwap_discount_pct": 0.66
},
{
"date": "2026-10-14",
"close": 55.14,
"vwap": 55.08,
"volume": 1845709,
"vwap_discount_pct": -0.1
},
{
"date": "2026-10-13",
"close": 54.38,
"vwap": 54.54,
"volume": 2661697,
"vwap_discount_pct": 0.29
}
],
"avg_vwap_discount_pct": 0.3,
"signal": "Accumulation"
},
"options_flow": [
{
"nbbo_ask": "2.70",
"option_chain_id": "BMRN261120C00055000",
"size": 50,
"premium": "11250.00",
"implied_volatility": "0.3755023994391486",
"volume": 50,
"executed_at": "2026-10-19T14:42:05.372000Z",
"nbbo_bid": "2.05",
"delta": "0.498165439424406",
"expiry": "2026-11-20",
"strike": "55",
"open_interest": 96,
"underlying_symbol": "BMRN",
"option_type": "call",
"underlying_price": "54.43",
"sector": "Healthcare",
"price": "2.25"
}
],
"net_premium": {
"ticker": "BMRN",
"net_call_premium": "-13015.00",
"net_put_premium": "6915.00",
"call_premium": "35550.00",
"put_premium": "6915.00",
"bullish_premium": "9215.00",
"bearish_premium": "29145.00",
"put_call_ratio": "0.0240549828178694158075601375",
"iv_rank": "45.3641",
"implied_move_perc": "0.08",
"gex_ratio": null,
"gex_net_change": null,
"gex_call": "49042.6796",
"gex_put": "-25653.9900",
"gex_net": 23388.6896,
"gex_call_delta": "656742.4835",
"gex_put_delta": "-399165.0745",
"gex_date": "2026-10-19"
},
"hot_chains": [
{
"underlying_symbol": "BMRN",
"expires": "2026-12-18",
"open_interest": 1,
"option_type": "call",
"delta": 0.127599133888121,
"ask_volume": 95,
"last_price": "0.50",
"implied_volatility": "0.3564739867317609",
"gamma": 0.0260679257374629,
"avg_price": "0.5000000000000000000000000000",
"bid_volume": 0,
"nbbo_ask": "0.50",
"strike": "65",
"option_symbol": "BMRN261218C00065000",
"total_premium": "4750.00",
"iv": 0.362717861504136,
"volume": 95,
"nbbo_bid": "0.30"
},
{
"underlying_symbol": "BMRN",
"expires": "2026-11-20",
"open_interest": 96,
"option_type": "call",
"delta": 0.48848085009865,
"ask_volume": 0,
"last_price": "2.30",
"implied_volatility": "0.3873990985633946",
"gamma": 0.058650926402274,
"avg_price": "2.2568965517241379310344827586",
"bid_volume": 58,
"nbbo_ask": "2.70",
"strike": "55",
"option_symbol": "BMRN261120C00055000",
"total_premium": "13090.00",
"iv": 0.420882094650738,
"volume": 58,
"nbbo_bid": "2.20"
},
{
"underlying_symbol": "BMRN",
"expires": "2026-11-20",
"open_interest": 83,
"option_type": "call",
"delta": 0.340483094522332,
"ask_volume": 0,
"last_price": "1.45",
"implied_volatility": "0.4003370694913876",
"gamma": 0.056771156091909,
"avg_price": "1.3439024390243902439024390244",
"bid_volume": 10,
"nbbo_ask": "1.60",
"strike": "57.5",
"option_symbol": "BMRN261120C00057500",
"total_premium": "5510.00",
"iv": 0.39974409488852,
"volume": 41,
"nbbo_bid": "1.35"
},
{
"underlying_symbol": "BMRN",
"expires": "2026-12-18",
"open_interest": 0,
"option_type": "call",
"delta": 0.396529100561059,
"ask_volume": 3,
"last_price": "2.30",
"implied_volatility": "0.3870242202579491",
"gamma": 0.0435931383612688,
"avg_price": "2.0272727272727272727272727273",
"bid_volume": 30,
"nbbo_ask": "2.30",
"strike": "57.5",
"option_symbol": "BMRN261218C00057500",
"total_premium": "6690.00",
"iv": 0.400346218409306,
"volume": 33,
"nbbo_bid": "2.00"
},
{
"underlying_symbol": "BMRN",
"expires": "2026-11-20",
"open_interest": 327,
"option_type": "call",
"delta": 0.227933600998862,
"ask_volume": 2,
"last_price": "0.80",
"implied_volatility": "0.4015879957935584",
"gamma": 0.0455306447367633,
"avg_price": "0.8650000000000000000000000000",
"bid_volume": 9,
"nbbo_ask": "0.95",
"strike": "60",
"option_symbol": "BMRN261120C00060000",
"total_premium": "1038.00",
"iv": 0.410746448384632,
"volume": 12,
"nbbo_bid": "0.75"
},
{
"underlying_symbol": "BMRN",
"expires": "2027-04-16",
"open_interest": 1001,
"option_type": "call",
"delta": 0.0383338849150023,
"ask_volume": 0,
"last_price": "0.10",
"implied_volatility": "0.3850038357331993",
"gamma": 0.00484519883133085,
"avg_price": "0.10",
"bid_volume": 10,
"nbbo_ask": "2.25",
"strike": "100",
"option_symbol": "BMRN270416C00100000",
"total_premium": "100.00",
"iv": 0.450953911264362,
"volume": 10,
"nbbo_bid": "0.00"
},
{
"underlying_symbol": "BMRN",
"expires": "2026-11-20",
"open_interest": 49,
"option_type": "call",
"delta": 0.109507350025595,
"ask_volume": 0,
"last_price": "0.20",
"implied_volatility": "0.3912747242941145",
"gamma": 0.0250662678465881,
"avg_price": "0.2000000000000000000000000000",
"bid_volume": 8,
"nbbo_ask": "0.55",
"strike": "65",
"option_symbol": "BMRN261120C00065000",
"total_premium": "160.00",
"iv": 0.462868191816232,
"volume": 8,
"nbbo_bid": "0.20"
},
{
"underlying_symbol": "BMRN",
"expires": "2028-06-16",
"open_interest": 1056,
"option_type": "call",
"delta": 0.252908688493658,
"ask_volume": 6,
"last_price": "3.32",
"implied_volatility": "0.3143436602393447",
"gamma": 0.01345892317691188,
"avg_price": "3.3250",
"bid_volume": 0,
"nbbo_ask": "3.70",
"strike": "80",
"option_symbol": "BMRN280616C00080000",
"total_premium": "1995.00",
"iv": 0.339011659790671,
"volume": 6,
"nbbo_bid": "2.80"
}
],
"gamma_profile": {
"ticker": "BMRN",
"spot": 54.375,
"date": "2026-10-19",
"flip_point": 60.53,
"net_gex": 23388.69,
"call_walls": [
{
"strike": 60.0,
"gex": 9443.01
},
{
"strike": 70.0,
"gex": 5965.25
},
{
"strike": 62.5,
"gex": 5316.14
}
],
"put_walls": [
{
"strike": 60.0,
"gex": -9100.99
},
{
"strike": 50.0,
"gex": -4220.86
},
{
"strike": 55.0,
"gex": -3018.17
}
],
"by_strike": [
{
"strike": 27.5,
"call_gex": 0.29,
"put_gex": -2.8,
"net_gex": -2.52
},
{
"strike": 30.0,
"call_gex": 4.95,
"put_gex": -2.72,
"net_gex": 2.23
},
{
"strike": 32.5,
"call_gex": 3.84,
"put_gex": -1.65,
"net_gex": 2.19
},
{
"strike": 35.0,
"call_gex": 36.26,
"put_gex": -6.01,
"net_gex": 30.25
},
{
"strike": 37.5,
"call_gex": 5.26,
"put_gex": -5.33,
"net_gex": -0.07
},
{
"strike": 40.0,
"call_gex": 130.69,
"put_gex": -51.2,
"net_gex": 79.49
},
{
"strike": 42.5,
"call_gex": 0.93,
"put_gex": -189.62,
"net_gex": -188.68
},
{
"strike": 45.0,
"call_gex": 345.95,
"put_gex": -863.78,
"net_gex": -517.83
},
{
"strike": 47.5,
"call_gex": 18.02,
"put_gex": -803.61,
"net_gex": -785.59
},
{
"strike": 50.0,
"call_gex": 670.34,
"put_gex": -4220.86,
"net_gex": -3550.52
},
{
"strike": 52.5,
"call_gex": 635.56,
"put_gex": -965.38,
"net_gex": -329.82
},
{
"strike": 55.0,
"call_gex": 4945.18,
"put_gex": -3018.17,
"net_gex": 1927.02
},
{
"strike": 57.5,
"call_gex": 5065.94,
"put_gex": -2994.42,
"net_gex": 2071.52
},
{
"strike": 60.0,
"call_gex": 9443.01,
"put_gex": -9100.99,
"net_gex": 342.02
},
{
"strike": 62.5,
"call_gex": 5316.14,
"put_gex": -941.03,
"net_gex": 4375.11
},
{
"strike": 65.0,
"call_gex": 1861.26,
"put_gex": -1705.14,
"net_gex": 156.12
},
{
"strike": 67.5,
"call_gex": 1633.53,
"put_gex": -251.91,
"net_gex": 1381.62
},
{
"strike": 70.0,
"call_gex": 5965.25,
"put_gex": -340.03,
"net_gex": 5625.22
},
{
"strike": 72.5,
"call_gex": 1517.35,
"put_gex": -20.44,
"net_gex": 1496.91
},
{
"strike": 75.0,
"call_gex": 5045.8,
"put_gex": -63.85,
"net_gex": 4981.96
},
{
"strike": 77.5,
"call_gex": 781.61,
"put_gex": 0.0,
"net_gex": 781.61
},
{
"strike": 80.0,
"call_gex": 2138.63,
"put_gex": -105.08,
"net_gex": 2033.55
},
{
"strike": 82.5,
"call_gex": 258.85,
"put_gex": 0.0,
"net_gex": 258.85
},
{
"strike": 85.0,
"call_gex": 731.75,
"put_gex": 0.0,
"net_gex": 731.75
},
{
"strike": 87.5,
"call_gex": 55.39,
"put_gex": 0.0,
"net_gex": 55.39
}
]
},
"oi_changes": {
"net_call_oi_change": -123,
"net_put_oi_change": 0,
"top": [
{
"strike": "60",
"oi_change": -124,
"type": "call"
},
{
"strike": "70",
"oi_change": 4,
"type": "call"
},
{
"strike": "75",
"oi_change": -4,
"type": "call"
},
{
"strike": "57.5",
"oi_change": 1,
"type": "call"
},
{
"strike": "60",
"oi_change": 0,
"type": "put"
}
]
},
"opds": {
"opds": 0.3,
"D": 1.3,
"P": -38.1,
"O": -35.6,
"C": 25.5,
"signal": "NEUTRAL",
"direction": "bullish",
"coverage": 0.5,
"ranked": true,
"components": {
"M": -18.7,
"T": -88.1,
"RS": 3.2,
"V": -50.8,
"F": -52.0,
"OI": -100.0,
"S": null,
"IV": null,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": 0.0,
"FlowAgreement": 100.0,
"StrikeBreadth": 16.7
},
"drivers": [
"- open-interest change -100",
"- trend -88",
"- aggressive flow -52",
"- price/volume -51"
]
}
}
Data:
{
"vix": 16.87,
"sp500": 7718.94,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.37,
"hy_spread": 3.16,
"treasury": {
"date": "2026-10-16",
"month1": 4.12,
"month2": 4.17,
"month3": 4.26,
"month6": 4.34,
"year1": 4.46,
"year2": 4.74,
"year3": 4.82,
"year5": 4.89,
"year7": 4.98,
"year10": 5.09,
"year20": 5.47,
"year30": 5.43
},
"events": []
}
Data:
{
"days": 103,
"patterns": [
{
"name": "VWAP Touch",
"count": 103,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 98,
"pct": 95
},
{
"name": "Woodie Pivot Touch",
"count": 95,
"pct": 92
},
{
"name": "PDH/PDL Touch",
"count": 92,
"pct": 89
},
{
"name": "Open Retracement",
"count": 69,
"pct": 67
},
{
"name": "Gap Fill",
"count": 63,
"pct": 61
},
{
"name": "Darvas Box",
"count": 24,
"pct": 23
},
{
"name": "High Vol Open",
"count": 23,
"pct": 22
},
{
"name": "Power Hour",
"count": 13,
"pct": 13
}
]
}